Vicarious Surgical Inc. (RBOT)
| Bid | 6.68 |
| Market Cap | 39.45M |
| Revenue (ttm) | 2.09M |
| Net Income (ttm) | -61.62M |
| EPS (ttm) | -10.44 |
| PE Ratio (ttm) | -0.64 |
| Forward PE | -0.98 |
| Analyst | Hold |
| Ask | 6.9 |
| Volume | 7,644 |
| Avg. Volume (20D) | 22,790 |
| Open | 6.86 |
| Previous Close | 6.85 |
| Day's Range | 6.61 - 6.93 |
| 52-Week Range | 4.27 - 19.00 |
| Beta | 1.47 |
About RBOT
undefined
Analyst Forecast
According to 0 analyst ratings, the average rating for RBOT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts
1 month ago · businesswire.com
Vicarious Surgical Receives Continued Listing Standard Notice from the NYSEWALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transf...
2 months ago · businesswire.com
Vicarious Surgical Announces President Transition to Board Member RoleWALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transf...
2 months ago · businesswire.com
Vicarious Surgical Reports Fourth Quarter and Full Year 2024 Financial ResultsWALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transf...